Net Cash Provided by (Used in) Operating Activities |
230M |
USD |
-19.3% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-790M |
USD |
-25.6% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
690M |
USD |
+93.3% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100K |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
55K |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
50 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
130M |
USD |
+900% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
259M |
USD |
-41.7% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
827M |
USD |
-14.7% |
Q4 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
663M |
USD |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
183M |
USD |
-18.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
827M |
USD |
-14.7% |
Q4 2023 |
FY 2023 |
Interest Expense |
1M |
USD |
0% |
Q2 2024 |
Q2 2024 |